Fig. 3From: Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survivalP53 immunostain in studied MIBC cases. A: Urothelial carcinoma showing p53 wild type staining score (+ 1) (× 200). B: High grade urothelial carcinoma with squamous differentiation showing mutant p53 staining pattern score + 2 (× 200)Back to article page